Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration 
Alphabet Stock Poised for Growth as Bank of America Sees Strong AI Momentum Into 2026 
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable” 
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures 
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand 
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
Coca-Cola Shelves Costa Coffee Sale After Low Private Equity Offers 
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 
LOS ANGELES, March 30, 2017 -- Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against DaVita Inc. (“DaVita” or the “Company”) (NYSE:DVA) concerning possible violations of federal securities laws between August 5, 2015 and October 21, 2016 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the April 3, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the complaint, during the Class Period, DaVita made false and/or misleading statements and/or failed to disclose: that the Company purposefully steered patients into unnecessary insurance plans in order to maximize profits; that DaVita was using the American Kidney Fund as a vehicle to facilitate these improper practices; that the Company’s revenues and profits were illegally obtained; that DaVita lacked effective internal controls over financial reporting; and that as a result of the above, the Company’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this news reached the public, the stock price of DaVita fell, causing investors harm.
Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/
